Bibliotecas PUC-SP - Busca Integrada

Virus-Based Immunotherapy of Glioblastoma

Por Miika Martikainen, Magnus Essand
Publicado no Cancers (2019-02-01)

The HDAC inhibitor FK228 enhances adenoviral transgene expression by a transduction-independent mechanism but does not increase adenovirus replication.

Por Angelika Danielsson, Helena Dzojic, Victoria Rashkova, Wing-Shing Cheng, Magnus Essand
Publicado no PLoS ONE (2011-01-01)

Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer

Por Alessandra Vaccaro, Tiarne van de Walle, Mohanraj Ramachandran, Magnus Essand, Anna Dimberg
Publicado no Frontiers in Immunology (2023-10-01)

Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer

Por Chuan Jin, Grammatiki Fotaki, Mohanraj Ramachandran, Berith Nilsson, Magnus Essand, Di Yu
Publicado no EMBO Molecular Medicine (2016-05-01)

Islet Engraftment and Revascularization in Clinical and Experimental Transplantation

Por Christian Molnár, Magnus Essand, Lars Wennberg, Christian Berne, Erik Larsson, Gunnar Tufveson, Olle Korsgren
Publicado no Cell Transplantation (2013-02-01)

Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors

Por Chuan Jin, Di Yu, Victoria Hillerdal, AnnaCarin Wallgren, Alex Karlsson-Parra, Magnus Essand
Publicado no Molecular Therapy: Methods & Clinical Development (2014-01-01)

Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response

Por Arwa Ali, Paola Contreras, Mahmoud Darweesh, Leif Andersson, Chuan Jin, Magnus Essand, Di Yu
Publicado no Molecular Therapy: Nucleic Acids (2024-12-01)

Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma

Por Tiarne van de Walle, Alessandra Vaccaro, Mohanraj Ramachandran, Ilkka Pietilä, Magnus Essand, Anna Dimberg
Publicado no Frontiers in Immunology (2021-09-01)

Immunological Shielding by Induced Recruitment of Regulatory T-Lymphocytes Delays Rejection of Islets Transplanted in Muscle

Por Evelina Vågesjö, Gustaf Christoffersson, Tomas B. Waldén, Per-Ola Carlsson, Magnus Essand, Olle Korsgren, Mia Phillipson
Publicado no Cell Transplantation (2015-02-01)

Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability.

Por Justyna Leja, Berith Nilsson, Di Yu, Elisabet Gustafson, Göran Akerström, Kjell Oberg, Valeria Giandomenico, Magnus Essand
Publicado no PLoS ONE (2010-01-01)

Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain

Por Jinar Rostami, Grammatiki Fotaki, Julien Sirois, Ropafadzo Mzezewa, Joakim Bergström, Magnus Essand, Luke Healy, Anna Erlandsson
Publicado no Journal of Neuroinflammation (2020-04-01)

Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses

Por Grammatiki Fotaki, Chuan Jin, Mohanraj Ramachandran, Iliana Kyriaki Kerzeli, Alex Karlsson-Parra, Di Yu, Magnus Essand
Publicado no OncoImmunology (2018-03-01)

Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-tumor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent resp...

Por Chuan Jin, Arwa Ali, Alexandros Iskantar, Grammatiki Fotaki, Hai Wang, Magnus Essand, Alex Karlsson-Parra, Di Yu
Publicado no OncoImmunology (2022-12-01)

IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma

Por Miika Martikainen, Mohanraj Ramachandran, Roberta Lugano, Jing Ma, Minttu-Maria Martikainen, Anna Dimberg, Di Yu, Andres Merits, Magnus Essand
Publicado no Molecular Therapy: Oncolytics (2021-06-01)

Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three m...

Por Grammatiki Fotaki, Chuan Jin, Iliana Kyriaki Kerzeli, Mohanraj Ramachandran, Minttu-Maria Martikainen, Alex Karlsson-Parra, Di Yu, Magnus Essand
Publicado no OncoImmunology (2018-03-01)

Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Por Therese Sjöholm, Alexander Korenyushkin, Gustav Gammelgård, Tina Sarén, Tanja Lövgren, Angelica Loskog, Magnus Essand, Joel Kullberg, Gunilla Enblad, Håkan Ahlström
Publicado no Cancer Imaging (2023-05-01)

Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Por Therese Sjöholm, Alexander Korenyushkin, Gustav Gammelgård, Tina Sarén, Tanja Lövgren, Angelica Loskog, Magnus Essand, Joel Kullberg, Gunilla Enblad, Håkan Ahlström
Publicado no Cancer Imaging (2022-12-01)

VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier

Por Miika Martikainen, Roberta Lugano, Ilkka Pietilä, Sofie Brosch, Camille Cabrolier, Aishwarya Sivaramakrishnan, Mohanraj Ramachandran, Di Yu, Anna Dimberg, Magnus Essand
Publicado no Nature Communications (2024-12-01)

Development of a New Hyaluronic Acid Based Redox-Responsive Nanohydrogel for the Encapsulation of Oncolytic Viruses for Cancer Immunotherapy

Por Siyuan Deng, Alessandra Iscaro, Giorgia Zambito, Yimin Mijiti, Marco Minicucci, Magnus Essand, Clemens Lowik, Munitta Muthana, Roberta Censi, Laura Mezzanotte, Piera Di Martino
Publicado no Nanomaterials (2021-01-01)

Complementarity-determining region clustering may cause CAR-T cell dysfunction

Por Tina Sarén, Giulia Saronio, Paula Marti Torrell, Xu Zhu, Josefin Thelander, Yasmin Andersson, Camilla Hofström, Marika Nestor, Anna Dimberg, Helena Persson, Mohanraj Ramachandran, Di Yu, Magnus Essand
Publicado no Nature Communications (2023-08-01)